| Literature DB >> 30337630 |
Chih-Hua Chao1,2, Ju-Chien Cheng3, Théo P Gonçalves4, Kuo-Wei Huang4, Chi-Chien Lin5,6, Hui-Chi Huang7, Syh-Yuan Hwang8, Yang-Chang Wu9,10,11.
Abstract
<span class="Disease">Glaulactams A-Cn> (1-3), which possess a novel skeleton, as well as the known compound <span class="Chemical">daphmanidin B (4), were isolated from the leaves of <span class="Species">Daphniphyllum glaucescens and separated using ion-exchange chromatography aided by NMR fingerprinting. Their structures, including their absolute configurations, were elucidated by spectroscopic analyses and time-dependent density-functional-theory-calculated electronic circular dichroism spectra; the data were subsequently analyzed to gain insight into the respective biogenetic relationships between the isolates, which exhibited anti-H1N1 and immunosuppressive activities.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30337630 PMCID: PMC6193994 DOI: 10.1038/s41598-018-33748-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures of compounds 1–3.
13C and 1H NMR spectroscopic data for 1–3 in pyridine-d5 (125/500 MHz).
| no. | 1 | 2 | 3 | ||||
|---|---|---|---|---|---|---|---|
| 13C | 1H (J in Hz) | 13C | 1H (J in Hz) | 13C | 1H (J in Hz) | ||
| 1 | 180.5 s | 181.6 s | 181.7 s | ||||
| 2 | 46.1 d | 2.37 m | 45.8 d | 2.27 m | 45.5 d | 2.15 m | |
| 3 | a | 35.9 t | 2.03 m | 28.9 t | 1.92 m | 27.7 t | 1.87 m |
| 3 | b | 2.75 m | 2.55 m | 2.91 m | |||
| 4 | a | 76.6 d | 5.51 dd (11.7, 3.6) | 36.3 t | 1.93 m | 35.2 t | 2.19 m |
| b | 2.16 m | 2.27 m | |||||
| 5 | 51.0 s | 45.9 s | 45.2 s | ||||
| 6 | 40.3 d | 3.12 m | 41.8 d | 2.85 m | 41.3 d | 2.97 m | |
| 7 | a | 45.8 t | 2.59 dd (13.3, 3.2) | 46.0 t | 2.56 dd (13.1, 3.3) | 43.9 t | 3.83 dd (13.3, 3.7) |
| b | 4.65 t (13.3) | 4.66 t (13.1) | 4.67 t (13.3) | ||||
| 8 | 134.1 s | 136.4 s | 126.7 s | ||||
| 9 | 143.3 s | 142.1 s | 148.7 s | ||||
| 10 | 134.6 s | 134.6 s | 168.2 s | ||||
| 11 | 120.9 d | 5.35 m | 120.3 d | 5.32 br d (5.4) | 27.7 t | 2.37 m | |
| 2.61 m | |||||||
| 12 | a | 33.2 t | 2.06 m | 32.9 t | 1.99 m | 25.9 t | 1.68 m |
| b | 2.72 m | 2.63 m | 2.22 m | ||||
| 13 | a | 42.4 t | 3.19 d (14.5) | 42.8 t | 2.90 d (15.2) | 134.2 d | 7.03 s |
| b | 3.76 m | 3.72 m | |||||
| 14 | 47.2 d | 3.27 t (7.9) | 46.6 d | 3.21 dd (7.6, 7.3) | 119.4 s | ||
| 15 | 54.3 d | 3.69 m | 54.3 d | 3.67 m | 160.2 s | ||
| 16 | a | 27.7 t | 1.09 m | 27.8 t | 1.11 m | 43.6 t | 2.74 m, 2H |
| b | 1.74 m | 1.73 m | |||||
| 17 | a | 38.5 t | 2.41 m | 38.4 t | 2.41 dd (14.4, 6.8) | 25.5 t | 2.77 m |
| b | 2.57 m | 2.59 m | 2.84 m | ||||
| 18 | 28.1 d | 2.33 m | 28.0 d | 2.30 m | 27.9 d | 2.29 m | |
| 19 | a | 51.4 t | 3.16 m, 2H | 51.8 t | 3.13 t (9.5) | 51.6 t | 3.17 t (9.7) |
| b | 3.16 t (9.5) | 3.22 t (9.7) | |||||
| 20 | 12.5 q | 1.25 d (6.7) | 12.6 q | 0.97 d (6.7) | 12.4 q | 1.00 d (7.0) | |
| 21 | a | 66.4 t | 4.06 d (11.6) | 73.0 t | 4.13 d (11.0) | 77.0 t | 3.91 d (11.0) |
| b | 5.03 d (11.6) | 4.40 d (11.0) | 4.47 d (11.0) | ||||
| 22 | 173.9 s | 173.9 s | 164.9 s | ||||
| 23 | 50.4 q | 3.59 s | 50.3 q | 3.59 s | 50.3 q | 3.75 s | |
| 4-OAc | 168.9 s | ||||||
| 20.1 q | 2.05 s | ||||||
| 21-OAc | 170.5 s | 170.8 s | 170.2 s | ||||
| 20.4 q | 2.07 s | 20.4 q | 2.15 s | 20.3 q | 2.13 s | ||
Figure 2Selected 1H–1H COSY and HMBC correlations in 1–3.
Figure 3Selected NOESY correlations in 1 and 3.
Figure 4Experimental (red) and calculated (blue) ECD spectra of 1.
Figure 5Plausible biogenetic pathways for 1–4.
Figure 6Cytotoxic (a) and anti-H1N1(b) activities of compounds 1–4. Betulinic acid was used as the positive control.
Figure 7(a) Cytotoxicities toward murine bone marrow-derived DCs in the presence of 100 ng/mL LPS for 24 h using the CCK-8 cell-counting assay. (b) TNF-α, (c) IL-6, and (d) IL-12 p70 cytokine levels determined by ELISA, and (e) NO determined using the Griess reagent. Data are expressed as means ± standard deviation (n = 3). Compounds 1–3 were used at 50 μg/mL and quercetin, the positive control, was used at 50 μM.